HOME
ABOUT
OUR DIFFERENCE
BRANDS
OUR PARTNERS
INVESTORS RELATIONS
CONTACT
More
Our medical cannabis inflorescences are grown under optimal and consistent conditions; and after, transferred to our EU-GMP Post-Harvest unit. Our first 4 strains will be available to consumers, in Q1 2021